Overall, we propose that specific patterns of editing in DLBCL (represented by the DLBCL cell line RC-K8) lead to activation to the NF-κB branch of the RLR pathway supporting tumor survival signaling. Here, NFKB1 is linked to diffuse large B-cell lymphoma.